The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Sophie D. Fosså

Department of Medical Oncology and Radiotherapy

Norwegian Radium Hospital



Name/email consistency: high



  • Department of Medical Oncology and Radiotherapy, Norwegian Radium Hospital, Norway. 1999 - 2005
  • The Norwegian Radiumhospital, Department of Clinical Cancer Research, Montebello 0310 Oslo, Norway. 2005
  • Norwegian Radium Hospital, Department of Oncology and Radiotherapy, Norway. 2003 - 2004
  • Norwegian Radium Hospital, Oslo. 2001 - 2003


  1. Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report. Fosså, S.D., Magelssen, H., Melve, K., Jacobsen, A.B., Langmark, F., Skjaerven, R. J. Natl. Cancer Inst. Monographs (2005) [Pubmed]
  2. Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948). Fosså, S.D., Paluchowska, B., Horwich, A., Kaiser, G., de Mulder, P.H., Koriakine, O., van Oosterom, A.T., de Prijck, L., Collette, L., de Wit, R. Br. J. Cancer (2005) [Pubmed]
  3. Increased mortality rates in young and middle-aged patients with malignant germ cell tumours. Fosså, S.D., Aass, N., Harvei, S., Tretli, S. Br. J. Cancer (2004) [Pubmed]
  4. Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer. Fosså, S.D. Acta. Oncol (2004) [Pubmed]
  5. Interferon-alpha-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma. Fosså, S.D., Mickisch, G.H., De Mulder, P.H., Horenblas, S., van Oosterom, A.T., van Poppel, H., Fey, M., Croles, J.J., de Prijck, L., Van Glabbeke, M. Cancer (2004) [Pubmed]
  6. Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). Fosså, S.D., de Wit, R., Roberts, J.T., Wilkinson, P.M., de Mulder, P.H., Mead, G.M., Cook, P., de Prijck, L., Stenning, S., Aaronson, N.K., Bottomley, A., Collette, L. J. Clin. Oncol. (2003) [Pubmed]
  7. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. Fosså, S.D., Dahl, A.A., Loge, J.H. J. Clin. Oncol. (2003) [Pubmed]
  8. Definitive radiotherapy of prostate cancer: the possible role of staging lymphadenectomy. Fosså, S.D., Lilleby, W., Waehre, H., Berner, A., Torlakovic, G., Paus, E., Olsen, D.R. Int. J. Radiat. Oncol. Biol. Phys. (2003) [Pubmed]
  9. Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy. Fosså, S.D., Aass, N., Heilo, A., Daugaard, G., E Skakkebaek, N., Stenwig, A.E., Nesland, J.M., Looijenga, L.H., Oosterhuis, J.W. Ann. Oncol. (2003) [Pubmed]
  10. Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer. Fosså, S.D., Dahl, A.A. J. Psychosom. Res (2002) [Pubmed]
  11. Long-term renal function after treatment for malignant germ-cell tumours. Fosså, S.D., Aass, N., Winderen, M., Börmer, O.P., Olsen, D.R. Ann. Oncol. (2002) [Pubmed]
  12. Liposomal doxorubicin (Caelyx) in symptomatic androgen-independent prostate cancer (AIPC)--delayed response and flare phenomenon should be considered. Fosså, S.D., Vaage, S., Letocha, H., Iversen, J., Risberg, T., Johannessen, D.C., Paus, E., Smedsrud, T. Scand. J. Urol. Nephrol. (2002) [Pubmed]
  13. Selection of patients may limit the generalizability of results from cancer trials. Fosså, S.D., Skovlund, E. Acta. Oncol (2002) [Pubmed]
  14. Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group. Fosså, S.D., Slee, P.H., Brausi, M., Horenblas, S., Hall, R.R., Hetherington, J.W., Aaronson, N., de Prijck L, , Collette, L. J. Clin. Oncol. (2001) [Pubmed]
  15. No randomised trial of prostate-cancer screening in Norway. Fosså, S.D., Eri, L.M., Skovlund, E., Tveter, K., Vatten, L. Lancet Oncol. (2001) [Pubmed]
  16. Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893. Fosså, S.D., Curran, D., Aaronson, N.K., Keuppens, F., Kliment, J., Robinson, M.R., DeReijke, T.M., Hetherington, J., Kil, P.J., Rea, L.A. Eur. Urol. (2000) [Pubmed]
  17. Health-related quality of life in patients treated for testicular cancer. Fosså, S.D., Dahl, A.A., Haaland, C.F. Curr. Opin. Urol (1999) [Pubmed]
WikiGenes - Universities